In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

IRhythm Technologies brings in $10mm through its Series B round

Executive Summary

IRhythm Technologies Inc. (cardiovascular monitoring devices) has raised just over $10mm through its Series B venture round. St. Jude Medical Inc. led and was joined by current shareholders Mohr Davidow Ventures and Synergy Life Science Partners and two other undisclosed investors. The company will use the proceeds to launch its Zio patch to provide continuous cardiac monitoring of ambulatory patients over a 14-day period. Concurrent with the financing, iRhythm announced a co-promotion agreement with St. Jude for the Zio patch and Zio event card, a cardiac rhythm monitor.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies